Cytosorbents Corp (CTSO) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CTSO.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 8 | $17 | $13 | $14.75 | $9.25 | 59.46% |
The Trend in the Analyst Price Target
CTSO's average price target has moved down $0 over the prior 112 days.
CTSO reports an average of 62.2% for its upside potential over the past 325 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2020-05-20 | 6 | 17 | 8 | 13.58 | 10.580 | 28.36% |
| 2020-07-20 | 6 | 17 | 8 | 14.00 | 11.545 | 21.26% |
| 2020-08-05 | 5 | 16 | 13 | 14.40 | 9.660 | 49.07% |
| 2020-08-11 | 5 | 16 | 13 | 14.60 | 9.290 | 57.16% |
| 2020-08-31 | 6 | 16 | 13 | 14.67 | 8.440 | 73.82% |
| 2020-09-16 | 7 | 16 | 13 | 14.71 | 8.310 | 77.02% |
| 2020-10-03 | 7 | 16 | 13 | 14.71 | 7.860 | 87.15% |
| 2020-10-25 | 7 | 16 | 13 | 14.71 | 8.300 | 77.23% |
| 2020-11-28 | 8 | 16 | 13 | 14.75 | 8.360 | 76.44% |
| 2020-12-07 | 8 | 16 | 13 | 14.75 | 8.040 | 83.46% |
| 2020-12-09 | 8 | 16 | 13 | 14.75 | 8.210 | 79.66% |
| 2020-12-19 | 8 | 16 | 13 | 14.75 | 8.480 | 73.94% |
| 2020-12-26 | 8 | 16 | 13 | 14.75 | 8.310 | 77.5% |
| 2021-01-02 | 8 | 16 | 13 | 14.75 | 7.970 | 85.07% |
| 2021-01-09 | 8 | 17 | 13 | 14.88 | 8.920 | 66.82% |
| 2021-01-16 | 8 | 17 | 13 | 14.88 | 8.580 | 73.43% |
| 2021-01-23 | 8 | 17 | 13 | 14.88 | 9.580 | 55.32% |
| 2021-01-30 | 8 | 17 | 13 | 14.88 | 10.490 | 41.85% |
| 2021-02-06 | 8 | 17 | 13 | 14.88 | 11.420 | 30.3% |
| 2021-02-13 | 8 | 17 | 13 | 14.88 | 11.380 | 30.76% |
| 2021-02-20 | 8 | 17 | 13 | 14.88 | 11.050 | 34.66% |
| 2021-02-27 | 8 | 17 | 13 | 14.88 | 9.420 | 57.96% |
| 2021-03-06 | 8 | 17 | 13 | 14.88 | 8.580 | 73.43% |
| 2021-03-13 | 8 | 17 | 13 | 14.88 | 8.690 | 71.23% |
| 2021-03-20 | 8 | 17 | 13 | 14.75 | 9.040 | 63.16% |
| 2021-04-03 | 8 | 17 | 13 | 14.75 | 8.800 | 67.61% |
| 2021-04-10 | 8 | 17 | 13 | 14.75 | 8.900 | 65.73% |
CTSO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.36 | 2 | 5 | 0 | 0 | 0 | 7 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CTSO as an investment opportunity.
- CTSO has a higher upside potential (average analyst target price relative to current price) than 79.15% of all US stocks.
- Cytosorbents Corp's average analyst price target is higher than 29.69% of all US stocks.
- CTSO has a higher number of analysts covering the stock than 93.5% of stocks in the small market cap category.
- CTSO has a less variance in analysts' estimates than 61.6% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to Cytosorbents Corp are ATEC, SIBN and ICAD.
What is the outlook for CTSO? Use POWR Ratings for clearer insight into price direction.